Dynatronics (DYNT) Lowered to “Hold” at Zacks Investment Research
Dynatronics (NASDAQ:DYNT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.
According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “
Shares of Dynatronics (NASDAQ:DYNT) traded up $0.10 during trading hours on Friday, reaching $3.15. 114,074 shares of the company were exchanged, compared to its average volume of 33,250. The company has a market capitalization of $15.99, a PE ratio of -2.81 and a beta of -0.09. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.46 and a quick ratio of 0.92. Dynatronics has a fifty-two week low of $2.10 and a fifty-two week high of $3.75.
Dynatronics (NASDAQ:DYNT) last announced its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.08. The business had revenue of $12.80 million for the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. sell-side analysts predict that Dynatronics will post -0.09 EPS for the current fiscal year.
In related news, major shareholder Ventures 1 Lp Provco bought 300,000 shares of the firm’s stock in a transaction on Thursday, November 30th. The shares were purchased at an average price of $2.50 per share, with a total value of $750,000.00. Following the completion of the purchase, the insider now owns 586,944 shares in the company, valued at approximately $1,467,360. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Stuart Essig bought 27,455 shares of the firm’s stock in a transaction on Wednesday, January 3rd. The shares were bought at an average cost of $2.77 per share, for a total transaction of $76,050.35. Following the purchase, the insider now owns 856,169 shares of the company’s stock, valued at approximately $2,371,588.13. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 369,015 shares of company stock worth $930,372. Insiders own 51.80% of the company’s stock.
An institutional investor recently bought a new position in Dynatronics stock. First Light Asset Management LLC bought a new position in shares of Dynatronics Co. (NASDAQ:DYNT) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the medical equipment provider’s stock, valued at approximately $280,000. First Light Asset Management LLC owned about 2.72% of Dynatronics as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 18.17% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Dynatronics (DYNT) Lowered to “Hold” at Zacks Investment Research” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2018/01/05/dynatronics-dynt-lowered-to-hold-at-zacks-investment-research.html.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.